1. Home
  2. MDBH vs LTRN Comparison

MDBH vs LTRN Comparison

Compare MDBH & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$2.93

Market Cap

32.3M

Sector

N/A

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$1.93

Market Cap

27.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
LTRN
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3M
27.6M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
MDBH
LTRN
Price
$2.93
$1.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2K
121.4K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$1.11
52 Week High
$4.80
$4.70

Technical Indicators

Market Signals
Indicator
MDBH
LTRN
Relative Strength Index (RSI) 46.35 23.63
Support Level $2.81 $1.11
Resistance Level $3.22 $2.41
Average True Range (ATR) 0.12 0.20
MACD -0.01 -0.02
Stochastic Oscillator 33.80 7.84

Price Performance

Historical Comparison
MDBH
LTRN

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The company operates in two reportable segments: a broker dealer & intellectual property service; and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: